Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL4

Research in Veterinary Science

Volumn 95, Issue 1, 2013, Pages 54-58

  Zhang, Wei ^a   Miao, JinFeng ^a   Li, PengFei ^a   Wang, YanXia ^a   Zhang, YuanShu ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

ACE; ACE2; Ang II; Ang(1 7); Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR MAS; RENIN; UNCLASSIFIED DRUG;

ACE GENE; ACE2 GENE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANG II GENE; ANG(1 7) GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AT1 GENE; CONTROLLED STUDY; FIBROGENESIS; GENE; GENE EXPRESSION; GENE LOCATION; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER FUNCTION; LIVER STRUCTURE; LIVER WEIGHT; MALE; MAS GENE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER CIRRHOSIS; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM; RNA; STATISTICS, NONPARAMETRIC; UP-REGULATION;

RATTUS;

EID: 84878127514     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2013.01.028     Document Type: Article

References (34)

1. Anderson P.H., Matthews J., Berrett S., Brush P., Patterson D. Changes in plasma enzyme activities and other blood components in response to acute and chronic liver damage in cattle. Research in Veterinary Science 1981, 31(1):1-4.
2. Bataller R., Ginès P., Nicolás J.M., Görbig M.N., Garcia-Ramallo E., Gasull X., Bosch J., Arroyo V., Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000, 118(6):1149-1156.
3. Bataller R., Gäbele E., Schoonhoven R., Morris T., Lehnert M., Yang L., Brenner D.A., Rippe R.A. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. American Journal of Physiology - Gastrointestinal and Liver Physiology 2003, 285(3):G642-G651.
4. Bataller R., Schwabe R.F., Choi Y.H., Yang L., Paik Y.H., Lindquist J., Qian T., Schoonhoven R., Hagedorn C.H., Lemasters J.J. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. Journal of Clinical Investigation 2003, 112(9):1383-1394.
5. Bataller R., Gäbele E., Parsons C.J., Morris T., Yang L., Schoonhoven R., Brenner D.A., Rippe R.A. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 2005, 41(5):1046-1055.
6. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., Oliveira-dos-Santos A.J., da Costa J., Zhang L., Pei Y. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002, 417(6891):822-828.
7. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation Research 2000, 87(5):e1-e9.
8. Guo H., Guo A., Wang C., Yan B., Lu H., Chen H. Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein. Research in Veterinary Science 2008, 84(3):494-496.
9. Herath C.B., Warner F.J., Lubel J.S., Dean R.G., Jia Z., Lew R.A., Smith A.I., Burrell L.M., Angus P.W. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. Journal of Hepatology 2007, 47(3):387-395.
10. Huang M., Li X., Meng Y., Xiao B., Ma Q., Ying S., Wu P., Zhang Z. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clinical and Experimental Pharmacology and Physiology 2010, 37(1):e1-e6.
11. Huang Q., Xie Q., Shi C.C., Xiang X.G., Lin L.Y., Gong B.D., Zhao G.D., Wang H., Jia N.N. Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis. International Journal of Molecular Medicine 2009, 23(6):717-723.
12. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436(7047):112-116.
13. Jonsson J.R., Clouston A.D., Ando Y., Kelemen L.I., Horn M.J., Adamson M.D., Purdie D.M., Powell E.E. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001, 121(1):148-155.
14. Kanno K., Tazuma S., Chayama K. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4. Biochemical and Biophysical Research Communications 2003, 308(1):177-183.
15. Kobayashi K., Imanishi T., Akasaka T. Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model. Hypertension Research 2006, 29(6):449-455.
16. Lee H.S., Kim H.H., Ku S.K. Hepatoprotective effects of Artemisiae capillaris herba and Picrorrhiza rhizoma combinations on carbon tetrachloride-induced subacute liver damage in rats. Nutrition Research 2008, 28(4):270-277.
17. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426(6965):450-454.
18. Nabeshima Y., Tazuma S., Kanno K., Hyogo H., Iwai M., Horiuchi M., Chayama K. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis. Biochemical and Biophysical Research Communications 2006, 346(3):658-664.
19. Oesterreicher C.H., Taura K., De Minicis S., Seki E., Penz-Oesterreicher M., Kodama Y., Kluwe J., Schuster M., Oudit G.Y., Penninger J.A., Brenner D.A. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 2009, 50(3):929-938.
20. Ohishi T., Saito H., Tsusaka K., Toda K., Inagaki H., Hamada Y., Kumagai N., Atsukawa K., Ishii H. Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology Research 2001, 21(2):147-158.
21. Paizis G., Cooper M.E., Schembri J.M., Tikellis C., Burrell L.M., Angus P.W. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002, 123(5):1667-1676.
22. Paizis G., Tikellis C., Cooper M.E., Schembri J.M., Lew R.A., Smith A.I., Shaw T., Warner F.J., Zuilli A., Burrell L.M. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005, 54(12):1790-1796.
23. Pereira R.M., dos Santos R.A.S., Teixeira M.M., Leite V.H.R., Costa L.P., da Costa Dias F.L., Barcelos L.S., Collares G.B., Simões e Silva A.C. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). Journal of Hepatology 2007, 46(4):674-681.
24. Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochemical Journal 2004, 383(Pt. 1):45-51.
25. Santos R.A.S., Ferreira A.J., Simões e Silva A.C. Recent advances in the angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis. Experimental Physiology 2008, 93(5):519-527.
26. Slater T. Free radicals and tissue injury: fact and fiction. The British Journal of Cancer. Supplement 1987, 8:5-10.
27. Terui Y., Saito T., Watanabe H., Togashi H., Kawata S., Kamada Y., Sakuta S. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology 2002, 36(4):1022.
28. Tikellis C., Johnston C.I., Forbes J.M., Burns W.C., Burrell L.M., Risvanis J., Cooper M.E. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003, 41(3):392-397.
29. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Journal of Biological Chemistry 2000, 275(43):33238-33243.
30. Wei H.S., Lu H.M., Li D.G., Zhan Y.T., Wang Z.R., Huang X., Cheng J.L., Xu Q.F. The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCl~ 4. World Journal of Gastroenterology 2000, 6(6):824-828.
31. Yang L., Bataller R., Dulyx J., Coffman T.M., Ginès P., Rippe R.A., Brenner D.A. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. Journal of Hepatology 2005, 43(2):317-323.
32. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Nakatani T., Tsujinoue H., Fukui H. Angiotensin II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001, 34(4):745-750.
33. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Yanase K., Namisaki T., Yamazaki M., Tsujinoue H., Imazu H. Angiotensin II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development. Hepatology Research 2003, 27(1):51-56.
34. Zangar R.C., Benson J.M., Burnett V.L., Springer D.L. Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes. Chemico-Biological Interactions 2000, 125(3):233-243.